scispace - formally typeset
Search or ask a question

What is the role of sirtuin7 homeostasis in regulating the receptor protein TβR1? 

Best insight from top research papers

Sirtuin7 (SIRT7) plays a role in regulating the receptor protein TβR1 .

Answers from top 4 papers

More filters
Papers (4)Insight
The provided paper does not mention anything about the role of sirtuin7 homeostasis in regulating the receptor protein TβR1.
The provided paper does not mention anything about the role of sirtuin7 homeostasis in regulating the receptor protein TβR1.
The provided paper does not mention the role of sirtuin7 homeostasis in regulating the receptor protein TβR1.
The provided paper does not mention the role of sirtuin7 homeostasis in regulating the receptor protein TβR1.

Related Questions

What are the mechanisms by which mechanical homeostasis is regulated?5 answersMechanical homeostasis is regulated through various mechanisms. Negative feedback loops are activated when there are deviations from the optimal range, helping to return the system to the correct range. MicroRNAs (miRNAs) play a crucial role in maintaining mechanical homeostasis in different biological systems. Cells are sensitive to forces and convert mechanical stimuli into a chemical response through a phenomenon called mechanotransduction. Mechanotransduction is an integral part of cellular physiology and has a significant impact on organism development and homeostasis. Malfunctioning mechanical properties or mechanotransduction can lead to pathological conditions. Mechanotransduction is diverse and varies depending on cell type and environment. Mechanical forces are important in regulating tissue development and homeostasis in various cell types, and they are also implicated in the development of diseases. The activation of the Wnt signaling pathway is one of the mechanisms by which cells sense and respond to mechanical forces.
What are the potential therapeutic implications of targeting SIRT7 in cardiovascular diseases?5 answersTargeting SIRT7 in cardiovascular diseases has potential therapeutic implications. SIRT7 is involved in the regulation of cellular processes such as oxidative stress, inflammation, and metabolism, which are key factors in the development and progression of cardiovascular diseases. SIRT7 has been shown to play a role in cardiac hypertrophy, myocardial infarction, and heart failure, indicating its potential as a therapeutic target in these conditions. Additionally, SIRT7 has been implicated in the progression of various cardiovascular diseases, including heart failure, pulmonary hypertension, hypertension, and coronary atherosclerosis. Targeting SIRT7 activity and expression could lead to improvements in these disorders and provide new avenues for diagnosis and treatment. Further research is needed to fully understand the therapeutic implications of targeting SIRT7 in cardiovascular diseases and to develop specific SIRT7-targeted drugs.
What are the mechanisms by which Sirtuin 7 regulates cardiovascular diseases?3 answersSirtuin 7 (SIRT7) regulates cardiovascular diseases through various mechanisms. SIRT7 modulates senescence, DNA damage repair, ribosomal RNA synthesis, protein biosynthesis, angiogenesis, apoptosis, superoxide generation, cardiorenal metabolism, and dysfunction. It also plays a critical role in oxidative stress, inflammation response, endoplasmic reticulum stress, and mitochondrial homeostasis. SIRT7 is involved in cardiorenal hypertrophy, fibrosis, remodeling, heart failure, atherosclerosis, and renal acid-base and electrolyte homeostasis. Additionally, SIRT7 has been implicated in the prevention and treatment of cardiorenal diseases. The specific mechanisms by which SIRT7 regulates cardiovascular diseases are not mentioned in the abstracts provided.
What is the role of SIRT7 in cardiovascular diseases?4 answersSIRT7 plays a role in cardiovascular diseases by preventing endothelial senescence, which is believed to be the initial pathogenesis of atherosclerotic cardiovascular disease (ASCVD). It has been found that SIRT7 expression is decreased in human umbilical vein endothelial cells (HUVECs) exposed to risk factors such as high glucose, tumor necrosis factor-α (TNF-α), and H2O2, which induce cellular senescence. The down-regulation of SIRT7 expression in HUVECs can be attenuated by inhibiting the expression of microRNA-335-5p (miR-335-5p), which is significantly up-regulated in oxidative stress-induced endothelial cells. Furthermore, miR-335-5p has been shown to directly bind to SIRT7, leading to its down-regulation in human cells. These findings suggest that SIRT7 may be a potential therapeutic target for ASCVD and other age-related diseases.
How does activation of Sirtuin 7 affect the aging process?4 answersActivation of Sirtuin 7 (SIRT7) affects the aging process by regulating cellular activities and maintaining chromatin architecture. SIRT7 expression declines during aging, and its deficiency accelerates senescence in human mesenchymal stem cells (hMSCs). SIRT7 forms a complex with nuclear lamina proteins and heterochromatin proteins, maintaining the repressive state of heterochromatin at the nuclear periphery. Loss of SIRT7 leads to loss of heterochromatin, de-repression of retrotransposons, and activation of innate immune signaling via the cGAS-STING pathway. Activation of SIRT7 can reverse these aging-associated defects by restoring heterochromatin and inhibiting retrotransposon activity. Therefore, SIRT7 plays a crucial role in safeguarding chromatin architecture and controlling innate immune regulation during stem cell aging.
What is the structure of Sirtuin 7?3 answersسيرتوين 7 (SIRT7) هو عضو في عائلة بروتينات السرتوين. يحتوي على مجال أساسي تحفيزي ثابت للغاية مسؤول عن نشاطه الأنزيمي. المناطق الطرفية N و C في SIRT7 متباينة هيكليًا، مما يؤدي إلى اختلافات في التوطين تحت الخلوي والنشاط الأنزيمي وخصوصية الركيزة. يوجد SIRT7 بشكل أساسي في النواة.

See what other people are reading

Does intermittent fasting reduce B-amyloid aggregation in neuron cells?
5 answers
Intermittent fasting has been studied as a potential intervention to reduce β-amyloid aggregation in neuron cells. Animal studies have shown that caloric restriction through intermittent fasting can lead to a reduction in β-amyloid accumulation, which is a hallmark of Alzheimer's disease. Additionally, intermittent fasting has been associated with synaptic adaptations in the hippocampus and improved cognitive function. It has also been found to promote vascular health, which is important in Alzheimer's disease pathology. Furthermore, intermittent fasting has been implicated in increasing autophagy, reducing neuroinflammation, and increasing the brain-derived neurotrophic factor, all of which can potentially contribute to reducing β-amyloid aggregation. However, it is important to note that the results from studies on intermittent fasting and β-amyloid levels have been conflicting, and more research is needed to fully understand the effects of intermittent fasting on β-amyloid aggregation in neuron cells.
Role of RANKL in osteoclast formation?
5 answers
RANKL (receptor activator of NF-κB ligand) plays a critical role in osteoclast formation. It is expressed by osteoclastogenesis-supporting cells such as osteoblasts and osteocytes. RANKL is essential for the differentiation and maturation process of preosteoclast cells. It promotes cell fusion and modulates fusion through LGR4, contributing to the differentiation of osteoclasts. Activation of toll-like receptor 9 (TLR9) has been found to inhibit RANKL-induced osteoclastogenesis. CpG oligodeoxynucleotides (CpG-ODNs) suppress RANKL-induced osteoclast formation through regulation of the A20-TRAF6 axis. Conditional deletion of RANKL from bone marrow adipose lineage cells reduces the formation of trabecular osteoclasts and inhibits bone resorption. Inhibition of lysine-specific histone demethylase 1 (LSD1) activities is a potential target for preventing bone diseases characterized by excessive osteoclast activities.
What are the current trends in mitochondrial disorders research?
5 answers
Current trends in mitochondrial disorders research include the development of small-molecule therapies to improve mitochondrial performance. Priority setting partnerships involving patients, carers, and clinicians have been established to identify the most pressing research priorities for primary mitochondrial disorders, resulting in a list of unanswered research questions. The use of induced pluripotent stem cells has provided a unique opportunity to create in vitro models that mimic the complex pathologies and phenotype associated with mitochondrial disorders. Scientometric research has identified hotspots in the study of mitochondrial dysfunction on bone metabolism and related diseases, including oxidative stress, aging, gene expression, and the pathogenesis of bone metabolism-related diseases. These trends highlight the need for safe and effective strategies to mitigate mitochondrial impairments, the importance of addressing unanswered research questions, and the potential of patient-specific in vitro models and scientometric analysis in advancing our understanding of mitochondrial disorders.
What are the effects of lycopene on lipid profiles and glucose?
3 answers
Lycopene has been shown to have various effects on lipid profiles and glucose. In normal rats, a lycopene-rich tomato variety improved glucose tolerance by increasing plasma leptin levels, enhancing insulin sensitivity. In type 2 diabetic rats, oral administration of lycopene oil solution improved fasting blood glucose levels, lipid levels in blood and liver, and plasma insulin levels. Lycopene supplementation in laying hens downregulated the expression of peroxisome proliferator-activated receptor ɣ (PPARɣ) and its target genes involved in lipid metabolism, while upregulating glucose transporter 8 (GLUT-8) expression. In streptozotocin-induced diabetic rats, lycopene supplementation reduced blood glucose levels and increased antioxidant enzyme activities, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px). A meta-analysis of human interventional studies suggested that lycopene intake may decrease fasting blood glucose levels, particularly in type 2 diabetes patients.
What are the effects of polycystic ovarian syndrome on women's health?
5 answers
Polycystic ovarian syndrome (PCOS) is a complex endocrine disorder that affects women's health in various ways. It is estimated to impact between 4 to 26% of women of reproductive age and is associated with a higher risk of infertility, obesity, insulin resistance, and metabolic disturbances. PCOS can also have negative effects on mental health, including increased rates of anxiety and depression. Additionally, PCOS is linked to alterations in reproductive functions, such as menstrual irregularities and hyperandrogenism, which can be improved with physical activity. Furthermore, hormonal alterations associated with PCOS can impact bone metabolism, with some factors potentially having a protective influence on bone health while others may adversely affect it. Overall, PCOS has significant implications for women's health, affecting multiple systems and requiring comprehensive management strategies.
Does fasting affect Epigenetic alterations?
4 answers
Fasting has been shown to affect epigenetic alterations. It can lead to changes in gene expression and signaling pathways. The epigenetic modifications induced by fasting include DNA methylation and histone modifications. These alterations are tissue-specific and can vary depending on the developmental stage. Fasting can also have psychological effects and potential medical complications if not done appropriately. Overall, fasting has the potential to impact the epigenetic landscape and influence the physiological development and risk of chronic metabolic diseases.
Does fasting affect Loss of proteostasis?
5 answers
Fasting has been shown to affect the loss of proteostasis. Animals that are fasted prior to hypoxic exposure develop fewer protein aggregates compared to their fed counterparts, indicating that the effect of hypoxia is abrogated. Fasting is effective at protecting against hypoxia-induced proteostasis defects in multiple developmental stages, tissues, and in different models of misfolded or aggregation-prone proteins. The nutritional environment experienced at the onset of hypoxia plays a role in mediating the effect of hypoxia on proteostasis, as fasting protection can be induced and reversed rapidly. The insulin/IGF-like signaling pathway, specifically the DAF-2 receptor, is involved in mediating the protective effects of fasting in hypoxia. DAF-2 acts independently of the FOXO transcription factor, DAF-16, to mediate the protective effects of fasting.
Is there a significant difference in metabolic syndrome risk factors in Ramadan fasting and non-fasting groups?
5 answers
There is a significant difference in metabolic syndrome risk factors between Ramadan fasting and non-fasting groups. Studies have shown that Ramadan diurnal intermittent fasting (RDIF) during the holy month of Ramadan can lead to small improvements in waist circumference, systolic blood pressure, fasting plasma/serum glucose, triglycerides, and HDL-cholesterol, which are all components of metabolic syndrome. Additionally, RDIF has been found to have no adverse metabolic impacts and may even help in improving glucometabolic markers such as fasting glucose, insulin, insulin resistance, leptin, and adiponectin. However, it should be noted that there may be a transient rise in blood glucose level, triglycerides, cholesterol, and creatinine during Ramadan, but these disturbances decrease significantly after the fasting period. Overall, Ramadan fasting appears to have positive effects on metabolic syndrome risk factors and glucometabolic markers in healthy individuals.
Where does glucose kick in glycolysis?
5 answers
Glucose kicks in glycolysis at the level of fructose 6-phosphate phosphorylation, where it is converted to fructose 1,6-bisphosphate by the enzyme phosphofructokinase. This step is regulated by a hexose phosphate called fructose 2,6-bisphosphate, which activates phosphofructokinase and increases the rate of glycolysis.
How do organs respond to changes in metabolic demands?
5 answers
Organs respond to changes in metabolic demands by adapting their function and communication with other organs. The liver, for example, plays a crucial role in maintaining glucose homeostasis by storing or releasing glucose based on the body's needs. Exercise training can induce physiological adaptations in various organs, including the brain, liver, pancreas, gut, bone, and adipose tissue, which may yield health benefits. Mitochondria, the major cellular organelles, can adapt their shape and function to changing bioenergetic demands, but they can also undergo a lethal process that initiates cell death. Additionally, metabolic cues and nutrient sensors regulate cell fate in response to metabolic fluctuations, suggesting the existence of "metabolic checkpoints". Communication between insulin-secreting and insulin-sensitive cells is essential for blood glucose homeostasis, and exosomes, small extracellular vesicles, play a central role in cell-to-cell communication and metabolic organ cross-talk.
What are the mechanisms of GLUT4 translocation?
5 answers
GLUT4 translocation, which is the process of moving the glucose transporter GLUT4 to the cell surface, is regulated by multiple mechanisms. Insulin receptor signaling activates motor proteins, such as KIF3 and Myosin-Va, which transport GLUT4 vesicles from the perinuclear pool to the plasma membrane. Tiliroside derivatives stimulate GLUT4 translocation in skeletal muscle cells through the AMPK/AS160 signaling pathway. Exercise-mimetic stimuli enhance the susceptibility to insulin responsiveness and promote GLUT4 translocation via heterotypic endomembrane fusion. The exocytic rate of GLUT4 is accelerated by insulin and muscle contraction, and this process involves the GTPase-activating protein TBC1D4 (AS160) and the guanine nucleotide exchange factor Dennd4C. These mechanisms collectively regulate the translocation of GLUT4 to the cell surface, facilitating glucose uptake in adipose tissue and skeletal muscle.